HealthEquity, Inc.
NASDAQHealthEquity enters the final stretch before its December earnings with a subtle but consistent shift in positioning: short sellers have been adding exposure for six weeks, options markets have turned more defensive, and the stock is trading roughly 22% below where analysts think it should be. The short-interest story is not alarming, but it has become harder to ignore. Short…
HQY put/call ratio collapses to 0.30, lowest in 52 weeks and 4.2 standard deviations below the 20-day mean—signaling extreme call dominance and maximum bullish sentiment.
Snapshot as of 13 Oct 2026
HealthEquity enters the final stretch before its December earnings with a subtle but consistent shift in positioning: short sellers have been adding exposure for six weeks, options markets have turned more defensive,…
HealthEquity heads into its September 1 earnings report with options traders suddenly far more defensive than the prior month's positioning would suggest. The sharpest signal is in the options market. The put/call…
HealthEquity cleared its June 2 earnings hurdle with a modest gain, but the post-print session has brought sellers back into the stock — and the options market, which was screaming bullish just days ago, has quietly…
HealthEquity heads into its June 2 earnings print with options traders making their most aggressively bullish bet of the past year. The sharpest signal in the data is the put/call ratio, which collapsed to 0.32 on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HQY — free to start on ORTEX.
Sign up for free →Open HQY on ORTEX